Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 477981 - 478000 out of 495978 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (J07BN01) covid-19, rna-based vaccine | COVID-19 VACCINE (PFIZER) 2024-2025 (6MO-4YR) | 10 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pfizer,Inc. |
| USA | (J07BX03) covid-19 vaccines | COVID-19 VACCINE MRNA (COMIRNATY) 2024-2025 | 10 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Pfizer,Inc. |
| USA | (L01EB01) gefitinib (adm: O) | GEFITINIB 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | AvKare,LLC |
| USA | (L01EB09) lazertinib | LAZCLUZE 240MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01EB09) lazertinib | LAZCLUZE 80MG TAB | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | J&JHealthCareSystemsonbehalfofJanssenBiotechInc. |
| USA | (L01FD01) trastuzumab | ONTRUZANT 150MG VIAL | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | OrganonLLC |
| USA | (L01XX05) hydroxycarbamide | HYDROXYUREA 500MG CAP | 100 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GoldenStateMedicalSupply,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,CROHN-UC-H | 6X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PSORIASIS- | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,PEN,PSORIASIS- | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | ADALIMUMAB-ADBM 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,PEN,PSORIASIS-UVEITIS | 4X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
| USA | (L04AB04) adalimumab (adm: P) | CYLTEZO 40MG/0.4ML INJ,SYRINGE,PKG,2 | 2X0.4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | BoehringerIngelheimPharmaceuticals,Inc. |
Pages
